Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves Johnson & Johnson’s nasal spray for depression
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants.
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.
US FDA approves J&J's ketamine-based therapy to treat depression
The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with major depressive disorder, the company said on Tuesday. The approval paves the way for use of Spravato in patients whose disease has stopped responding to at least two oral anti-depressants.
FDA allows standalone use of nasal spray antidepressant Spravato
The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression.
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.
1d
on MSN
Blue Monday isn’t real, but seasonal depression affects millions of people. There are ways to treat it
Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of ...
20h
What's the Connection Between Weight & Depression?
Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...
New Atlas
7d
Depression breakthrough: Almost 300 previously unknown genes identified
We've never been closer to accurately assessing whether an individual is more susceptible to developing major depressive ...
1d
on MSN
Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories
Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories ...
14h
on MSN
Drawing a line from the gut microbiome to inflammation and depression
It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...
1d
France has the highest levels of depression in Europe. How does it compare with other countries?
A new report studied depression levels across Europe and in older and younger individuals, with the outlook for France ...
2h
Probation for man with symptoms of depression who ill-treated sons, aged 2 and 7
The man, who cannot be named due to a gag order, committed the offences in April 2020. Read more at straitstimes.com.
17h
EastEnders’ Phil Mitchell attempts suicide as depression spirals in harrowing new mental health storyline
EASTENDERS’ Phil Mitchell battles with his mental health in a harrowing new storyline as depression spirals and he attempts ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
United States
Spravato
Blue Monday
Johnson & Johnson
Food and Drug Administration
Feedback